Perinatal iron restriction is associated with changes in neonatal cardiac function and structure in a sex-dependent

Ronan M N Noble1,2, Claudia D Holody1,2, Andrew G Woodman3

  • 1Department of Pediatrics, University of Alberta, Edmonton, Canada.

Insights

Iron deficiency in pregnant rats impacts offspring heart development, causing distinct systolic and diastolic dysfunctions in males and females, respectively. These findings highlight critical risks for neonatal cardiac health.

Area of Science:

  • Developmental Biology
  • Cardiovascular Physiology
  • Nutritional Science

Background:

  • Iron deficiency (ID) and anemia are prevalent in pregnancy and infancy, potentially affecting long-term cardiovascular health.
  • Limited understanding exists regarding the specific impacts of perinatal iron deficiency on neonatal cardiac development and function.

Purpose of the Study:

  • To investigate the effects of maternal iron deficiency on the cardiac development and function of offspring during the neonatal period.
  • To identify sex-specific cardiac functional impairments and underlying molecular mechanisms in neonates exposed to iron deficiency in utero.

Main Methods:

  • Female Sprague-Dawley rats received either an iron-restricted or iron-replete diet before and during gestation.
  • Offspring cardiac function was evaluated using echocardiography on postnatal days 4, 14, and 28.
  • Quantitative shotgun proteomics was performed on heart tissues from a separate cohort of offspring.

Main Results:

  • Iron deficiency led to reduced body weight and increased relative heart weights in offspring across all assessed time points.
  • Echocardiography revealed sex-specific cardiac dysfunction: males exhibited greater systolic impairment, while females showed greater diastolic impairment.
  • Proteomic analysis indicated downregulation of structural proteins and enriched cellular stress responses in iron-deficient offspring, with more pronounced effects in males.

Conclusions:

  • Perinatal iron deficiency induces functional cardiac changes in neonates, potentially representing maladaptive compensation to anemia.
  • Systolic and diastolic dysfunctions are identified as comorbidities of perinatal iron deficiency anemia, with implications for neonatal cardiac health.
  • Therapeutic strategies aimed at improving cardiac output may offer a means to mitigate the adverse effects of iron deficiency on neonatal organ development.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.1K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K